Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Guadagni

Showing results (41-50 of 96) with videos related to

Pageof 10
Sort By:
Geburtshilfe Und Frauenheilkunde|April 1, 1995
[Value of the TAG-72 (CA 72-4) tumor marker in primary diagnosis of ovarian carcinoma. A comparison with the established CA-125 marker]A G Zeimet, F Guadagni, C Marth, et al.
Thrombosis and Haemostasis|March 2, 2011
An activated protein C-dependent thrombin generation assay predicts chemotherapy-associated venous thromboembolism in cancer patientsP Ferroni, F Martini, I Portarena, et al.
In Vivo (Athens, Greece)|November 1, 1993
Clinical value of radiolabeled monoclonal antibodies in the management of carcinoma patientsM Roselli, F Guadagni, O Buonomo, et al.
Diseases of the Colon and Rectum|February 1, 1994
Biologic evaluation of tumor-associated glycoprotein-72 and carcinoembryonic antigen expression in colorectal cancer, Part IF Guadagni, M Roselli, M Cosimelli, et al.
Anticancer Research|March 1, 1996
Intraoperative radioimmunolocalization of an anti-CEA MAb F(Ab')2 (FO23C5) in CEA serum-negative colorectal cancer patientsM Roselli, F Guadagni, O Buonomo, et al.
American Journal of Obstetrics and Gynecology|November 1, 1994
Evaluation of tumor-associated glycoprotein-72 and CA 125 serum markers in patients with gynecologic diseasesF Guadagni, C Marth, A G Zeimet, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1992
Intraperitoneal administration of interferon-gamma to carcinoma patients enhances expression of tumor-associated glycoprotein-72 and carcinoembryonic antigen on malignant ascites cellsJ W Greiner, F Guadagni, D Goldstein, et al.
Anticancer Research|November 1, 1993
Correlation between positive CA 72-4 serum levels and lymph node involvement in patients with gastric carcinomaF Guadagni, M Roselli, M Cosimelli, et al.
Journal of Surgical Oncology. Supplement|January 1, 1991
Clinical evaluation of serum tumor-associated glycoprotein-72 as a novel tumor marker for colorectal cancer patientsF Guadagni, M Roselli, T Amato, et al.
International Journal of Radiation Applications and Instrumentation. Part B, Nuclear Medicine and Biology|January 1, 1991
New concepts in monoclonal antibody based radioimmunodiagnosis and radioimmunotherapy of carcinomaJ Schlom, D E Milenic, M Roselli, et al.
Pageof 10

Showing results (41-50 of 96) with videos related to

Sort By:
Pageof 10
Geburtshilfe Und Frauenheilkunde|April 1, 1995
[Value of the TAG-72 (CA 72-4) tumor marker in primary diagnosis of ovarian carcinoma. A comparison with the established CA-125 marker]A G Zeimet, F Guadagni, C Marth, et al.
Thrombosis and Haemostasis|March 2, 2011
An activated protein C-dependent thrombin generation assay predicts chemotherapy-associated venous thromboembolism in cancer patientsP Ferroni, F Martini, I Portarena, et al.
In Vivo (Athens, Greece)|November 1, 1993
Clinical value of radiolabeled monoclonal antibodies in the management of carcinoma patientsM Roselli, F Guadagni, O Buonomo, et al.
Diseases of the Colon and Rectum|February 1, 1994
Biologic evaluation of tumor-associated glycoprotein-72 and carcinoembryonic antigen expression in colorectal cancer, Part IF Guadagni, M Roselli, M Cosimelli, et al.
Anticancer Research|March 1, 1996
Intraoperative radioimmunolocalization of an anti-CEA MAb F(Ab')2 (FO23C5) in CEA serum-negative colorectal cancer patientsM Roselli, F Guadagni, O Buonomo, et al.
American Journal of Obstetrics and Gynecology|November 1, 1994
Evaluation of tumor-associated glycoprotein-72 and CA 125 serum markers in patients with gynecologic diseasesF Guadagni, C Marth, A G Zeimet, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1992
Intraperitoneal administration of interferon-gamma to carcinoma patients enhances expression of tumor-associated glycoprotein-72 and carcinoembryonic antigen on malignant ascites cellsJ W Greiner, F Guadagni, D Goldstein, et al.
Anticancer Research|November 1, 1993
Correlation between positive CA 72-4 serum levels and lymph node involvement in patients with gastric carcinomaF Guadagni, M Roselli, M Cosimelli, et al.
Journal of Surgical Oncology. Supplement|January 1, 1991
Clinical evaluation of serum tumor-associated glycoprotein-72 as a novel tumor marker for colorectal cancer patientsF Guadagni, M Roselli, T Amato, et al.
International Journal of Radiation Applications and Instrumentation. Part B, Nuclear Medicine and Biology|January 1, 1991
New concepts in monoclonal antibody based radioimmunodiagnosis and radioimmunotherapy of carcinomaJ Schlom, D E Milenic, M Roselli, et al.
Pageof 10